Skip to content
10-Q

Quarterly Report

MediXall Group, Inc.

0001079973-24-000706

← back to feed
Filed
May 14, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · May 7, 2024 159.76M sh
Current Liabilities Q1 2023 · Mar 31, 2023 $4.99M
Current Liabilities Q1 2023 · Dec 31, 2022 $4.34M
Total Liabilities Q1 2023 · Mar 31, 2023 $4.99M
Total Liabilities Q1 2023 · Dec 31, 2022 $4.53M
Current Assets Q1 2023 · Mar 31, 2023 $5.77K
Current Assets Q1 2023 · Dec 31, 2022 $11.5K
Total Assets Q1 2023 · Mar 31, 2023 $618.18K
Total Assets Q1 2023 · Dec 31, 2022 $862.01K
Shares Diluted Q1 2023 · Mar 31, 2022 114.63M sh
Operating Cash Flow Q1 2023 · Mar 31, 2022 −$1.13M
Stockholders Equity Q1 2023 · Mar 31, 2022 −$675.5K
Stockholders Equity Q1 2023 · Dec 31, 2021 −$340.12K
Eps Diluted Q1 2023 · Mar 31, 2022 −$0.02
Eps Basic Q1 2023 · Mar 31, 2022 −$0.02
Net Income Q1 2023 · Mar 31, 2022 −$2.41M
Gross Profit Q1 2023 · Mar 31, 2022 $7.91K
Cost Of Revenue Q1 2023 · Mar 31, 2022 $0
Revenue Q1 2023 · Mar 31, 2022 $7.91K